期刊
CURRENT PHARMACEUTICAL DESIGN
卷 27, 期 11, 页码 1396-1406出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612826666201106091527
关键词
Hypertension; therapy; drug; intervention; novel; blood pressure
Essential hypertension is a crucial factor in global cardiovascular diseases and mortality, highlighting the need for continuous research and development of novel agents with good tolerability to manage uncontrolled hypertension. Future strategies may involve personalized approaches and genetic modulation in the treatment of hypertension.
Essential hypertension is an important cause of cardiovascular morbidity and mortality worldwide with significant clinical and economic implications. The field of antihypertensive treatment already numbers numerous agents and classes of drugs. However, patients are still developing uncontrolled hypertension. Hence there is a continuous need for novel agents with good tolerability. Advances in this field are focusing both on pharmacotherapy, with the developments in traditional and non-traditional targets, as well as interventional techniques such as renal denervation and baroreflex activation therapy. It is likely that future strategies may involve a tailored approach to the individual patient, with genetic modulation playing a key role.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据